FDA Warns California API Facility for Serious Violations

Drug Industry Daily
A A
The FDA issued a warning letter to Spectrum Laboratory Products’ Gardena, California facility for releasing adulterated and misbranded drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily